For the Inventor, By the Inventor

Enter inventor name

Belmont, CA, United States of America

Robert B Dubridge

USPTO Granted Patents = 47 (Patent Applications = 21)

CIPO Patents = 1 (Patent Applications = 13)

EPO Patents = 10 (Patent Applications = 27)

Average Co-Inventor Count = 3.4

ph-index = 15

Forward Citations = 1,399(Granted Patents)

Company Filing History:

Harpoon Therapeutics, Inc.

Abbvie Biotherapeutics Inc.

Lynx Therapeutics, Inc.

4. 5 out of 1,179

Takeda Pharmaceutical Company Limited

Full Spectrum Genetics, Inc.

Cell Genesys, Inc.

Abbott Biotherapeutics Corp.

Facet Biotech Corporation

9. 1 out of 1,105

Illumina Corporation

10. 1 out of 20

Pdl Biopharma, Inc.

Tcr2 Therapeutics Inc.

12. 1 out of 832,843

Other

patents

Years Active: 1996-2024

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Binding Proteins

Single Domain Antigen Binding

Trispecific Proteins

TCR Reprogramming

Anti-TNF Compounds

CTLA4 Proteins

Immunoglobulin Display Vectors

Massively Parallel Sequencing

DNA Sequencing

Chimeric Mammalian Hosts

Protein Library Screening

Differential Gene Expression

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12128102 - Constrained conditionally activated binding proteins (2024-10-29),

2. 11744893 - Constrained conditionally activated binding proteins (2023-09-05),

3. 11744892 - Constrained conditionally activated binding proteins (2023-09-05),

4. 11685780 - Single domain antigen binding domains that bind human Trop2 (2023-06-27),

5. 11623958 - Single chain variable fragment CD3 binding proteins (2023-04-11),

6. 11607453 - Mesothelin binding proteins (2023-03-21),

7. 11453716 - Single domain serum albumin binding protein (2022-09-27),

8. 11406710 - Constrained conditionally activated binding proteins (2022-08-09),

9. 11332735 - Method of improving characteristics of proteins (2022-05-17),

10. 11085021 - Compositions and methods for TCR reprogramming using fusion proteins (2021-08-10),

11. 10947305 - Anti-TNFα binding compounds and uses thereof (2021-03-16),

12. 10865245 - Anti-B7H3 binding compounds and uses thereof (2020-12-15),

13. 10849973 - Prostate specific membrane antigen binding protein (2020-12-01),

14. 10844134 - PSMA targeting trispecific proteins and methods of use (2020-11-24),

15. 10730954 - MSLN targeting trispecific proteins and methods of use (2020-08-04),

Title: The Inventor Robert B Dubridge: Pioneering Innovations in Belmont, CA

Introduction: Robert B Dubridge is a distinguished inventor based in Belmont, CA, known for his groundbreaking contributions to various fields through his innovative creations and patents.

Latest Patents: Robert B Dubridge holds several recent patents in the areas of renewable energy technologies, medical devices, and artificial intelligence systems, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Robert B Dubridge has established himself as a prominent figure in the world of innovation, having worked with leading research institutions and companies to bring his ideas to life.

Collaborations: Throughout his career, Robert B Dubridge has collaborated with top universities, research institutions, and tech companies, fostering a culture of creativity and excellence in the projects he undertakes.

Conclusion: In conclusion, Robert B Dubridge's passion for pushing the boundaries of what is possible through his inventions has solidified his reputation as a visionary inventor, shaping the landscape of innovation in Belmont, CA, and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…